• Q1 Financial Performance: Revenue grew 19% year-on-year to ₹476 crore, EBITDA increased 20% to ₹126 crore (26.50% margin), and PAT climbed 35% to ₹89 crore.
• Bed Capacity Expansion: Following recent additions in Agra, Panchkula, and Rudrapur that brought total capacity to 4,290 beds, the company targets 4,740 beds this financial year and 5,740 beds in FY 27–28.
• New Asset Projections: The newly launched Rudrapur hospital is expected to generate ₹100 crore in annual revenue with ₹20–22 crore in EBITDA, while Meher Hospital is targeted to generate ₹70–75 crore in revenue within one year post its November 2026 implementation.
• Occupancy and Margins: Occupancy dropped from 68% to 56% due to ~1,000 recent bed additions but is expected to rebound to ~65%, while EBITDA margins are projected to remain stable at 26–27%.
• ARPOB Growth Drivers: ARPOB increased approximately 12% from ₹27,500 to ₹30,500, supported by a product mix shift toward super-specialty and quaternary care as well as benefits from the CGHS rate revision.